The Johns Hopkins team used a microshell made of a sugar - based polymer called cyclodextrin to protect the 3BrPA drug molecules from disintegrating early and to guard healthy tissue from the drug's toxic effects, such as weight loss, hypothermia and
lethal hypoglycemic shock.